Skip to main content
Log in

The clinical role of critical pathway implementation for pancreaticoduodenectomy in 179 patients

  • Original article
  • Published:
Journal of Hepato-Biliary-Pancreatic Sciences

Abstract

Background/purpose

In June 2004, a critical pathway for patients undergoing pancreaticoduodenectomy (PD) was introduced. The objective of this study was to determine the clinical value of critical pathway implementation.

Methods

256 consecutive patients who underwent PD between 2000 and 2010 were divided into 4 groups by date of operation as follows; group A (n = 77), the pre-pathway group; group B (n = 51), the CP implementation group who were managed according to departmental guidelines; group C (n = 78), the group who had no stenting in the reconstruction of PD; and group D (n = 50), the group who had reinforcement of the pancreaticojejunostomy. The success rates of clinical outcomes and post-operative morbidity were compared between each group, year by year and every 50 patients.

Results

The success rates of clinical outcomes, including the timings of nasogastric tube removal, discontinuation of prophylactic anti-microbial agent, drain removal, starting oral intake, and patient discharge, were significantly improved in group B relative to group A, and in group C relative to group B. There were no significant differences in mortality and morbidity between any of the groups. All clinical outcomes reached a plateau at 2–3 years or 100–150 patients’ operations after critical pathway implementation.

Conclusions

Long-term use of a critical pathway is associated with improved clinical outcomes. A certain period of time or volume of patients is needed for this improvement in clinical outcomes to reach a plateau, which indicates achieving standardization of peri-operative management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Neoptolemos JP, Russel RC, Bramhall S, Theis B. Low mortality following resection for pancreatic and peri-ampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg. 1997;84:1370–6.

    Article  PubMed  CAS  Google Scholar 

  2. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. Ann Surg. 1997;226:248–60.

    Article  PubMed  CAS  Google Scholar 

  3. Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786–95.

    Article  PubMed  CAS  Google Scholar 

  4. Gouillat C, Gigot JF. Pancreatic surgical complications—the case for prophylaxis. Gut. 2001;49:32–9.

    Article  Google Scholar 

  5. Satoi S, Takai S, Matsui Y, Terakawa N, Iwaki R, Fukui J, et al. Less morbidity after pancreaticoduodenectomy of patients with pancreatic cancer. Pancreas. 2006;33:45–52.

    Article  PubMed  Google Scholar 

  6. Muller S, Zalunardo MP, Hubner M, Clavien PA, Zurich Fast Track Study Group. A fast-track program reduces complications and length of hospital stay after open colonic surgery. Gastroenterology. 2009;136:842–7.

    Article  PubMed  Google Scholar 

  7. Pritts TA, Nussbaum MS, Flesch LV, Fegelman EJ, Parikh AA, Fischer JE. Implementation of a clinical pathway decreases length of stay and cost for bowel resection. Ann Surg. 1999;230:728–33.

    Article  PubMed  CAS  Google Scholar 

  8. Cerfolio RJ, Bryant AS, Bass CS, Alexander JR, Bartolucci AA. Fast tracking after Ivor Lewis esophagogastrectomy. Chest. 2004;126:1187–94.

    Article  PubMed  Google Scholar 

  9. Huber TS, Carlton LM, Harward TRS, Russin MM, Phillips PT, Nalli BJ, et al. Impact of a clinical pathway for elective infrarenal aortic reconstructions. Ann Surg. 1998;227:691–701.

    Article  PubMed  CAS  Google Scholar 

  10. Leibman BD, Dillioglugil O, Abbas F, Tanli S, Kattan MW, Scardino PT. Impact of a clinical pathway for radical retropubic prostatectomy. Urology. 1998;52:94–9.

    Article  PubMed  CAS  Google Scholar 

  11. Markey DW, McGowan J, Hanks JB. The effect of clinical pathway implementation on total hospital costs for thyroidectomy and parathyroidectomy patients. Am Surg. 2000;66:533–8.

    PubMed  CAS  Google Scholar 

  12. Kennedy EP, Rosato EL, Sauter PK, Rosenberg LM, Doria C, Marino IR, et al. Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution—the first step in multidisciplinary team building. J Am Coll Surg. 2007;204:917–24.

    Article  PubMed  Google Scholar 

  13. Vanounou T, Pratt W, Fischer JE, Vollmer CM, Callery MP. Deviation-based cost modeling: a novel model to evaluate the clinical and economic impact of clinical pathways. J Am Coll Surg. 2007;204:570–9.

    Article  PubMed  Google Scholar 

  14. Porter GA, Pisters PW, Mansyur C, Bisanz A, Kim R, Stanford P, et al. Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol. 2000;7:484–9.

    Article  PubMed  CAS  Google Scholar 

  15. Balzano G, Zerbi A, Braga M, Rocchetti S, Beneduce AA, Di Carlo V. Fast-track recovery programme after pancreaticoduodenectomy reduces delayed gastric emptying. Br J Surg. 2008;95:1387–93.

    Article  PubMed  CAS  Google Scholar 

  16. Pitt HA, Murray KP, Bowman HM, Coleman JA, Gordon TA, Yeo CJ, et al. Clinical pathway implementation improves outcomes for complex biliary surgery. Surgery. 1999;126:751–8.

    Article  PubMed  CAS  Google Scholar 

  17. Satoi S, Toyokawa H, Yanagimoto H, Yamamoto T, Yamao J, Kim S, et al. A new guideline to reduce postoperative morbidity after pancreaticoduodenectomy. Pancreas. 2008;37:128–33.

    Article  PubMed  Google Scholar 

  18. Satoi S, Toyokawa H, Yanagimoto H, Yamamoto T, Hirooka S, Yui R, et al. Is a nonstented duct-to-mucosa anastomosis using the modified Kakita method a safe procedure? Pancreas. 2010;39:165–70.

    Article  PubMed  Google Scholar 

  19. Satoi S, Toyokawa H, Yanagimoto H, Yamamoto T, Hirooka S, Yui R, et al. Reinforcement of pancreaticojejunostomy using polyglycolic acid mesh and fibrin glue sealant. Pancreas. 2011;40:16–20.

    Article  PubMed  CAS  Google Scholar 

  20. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.

    Article  PubMed  Google Scholar 

  21. Campbell H, Hotchkiss R, Bradshaw N, Porteous M. Integrated care pathways. BMJ. 1998;316:133–7.

    Article  PubMed  CAS  Google Scholar 

  22. Kawai M, Tani M, Terasawa H, Ina S, Hirono S, Nishioka R, et al. Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg. 2006;244:1–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sohei Satoi.

About this article

Cite this article

Yamaki, S., Satoi, S., Toyokawa, H. et al. The clinical role of critical pathway implementation for pancreaticoduodenectomy in 179 patients. J Hepatobiliary Pancreat Sci 20, 271–278 (2013). https://doi.org/10.1007/s00534-012-0506-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-012-0506-x

Keywords

Navigation